The most frequent structural chromosome abnormality in chronic lymphocytic leukaemia (CLL) is deletion at chromosome 13q14. Studies with Southern blot hybridisation have revealed deletions in the region located telomeric of the retinoblastoma gene in more than 40% of cases. The highest frequency of homozygous deletions has been found at the D13S319 locus and it is likely that a new tumour suppressor gene is located close to this region. We have analysed deletions in the D13S319 region in 20 selected CLL patients using conventional cytogenetic analysis, fluorescence in situ hybridisation (FISH) and Southern blot hybridisation. FISH and Southern hybridisation are equally efficient in detecting deleted clones in our study. However, FISH analysis indicate that subclones with different numbers of alleles in the D13S319 region can exist simultaneously. The cytogenetic analyses confirm that clones with different chromosomal abnormalities can occur in patients with CLL and that 13q14 deletions can be limited to one of these subclones. Furthermore, the FISH analyses show that trisomy 12 and deletion of 13q14 can occur in the same cell clone. Finally, our study confirms that mitogen stimulation of peripheral blood cells from CLL patients before FISH analysis may result in a sharp increase in normal appearing cells, which can hide leukaemic clones with deletions in the D13S319 region.
Introduction
Tumour suppressor genes function to prevent malignant transformation. Genetic events such as larger deletions or small point mutations, affecting both alleles of the gene can result in impaired expression or a functional change in the corresponding protein, resulting in the development of malignant disease. 1 Findings from several studies have indicated that a previously unknown tumour suppressor gene, relevant for the development of chronic lymphocytic leukaemia (CLL), is located on chromosome 13. Cytogenetic analyses have shown deletions of 13q in approximately 10% of cases 2, 3 and this subgroup of CLL patients also had a better survival.
Early molecular analyses revealed that the retinoblastoma (Rb) gene was outside the region of interest [4] [5] [6] [7] and subsequent studies showed that the D13S319 (Mgg15) locus, between Rb and D13S25, had the highest frequency of deletions including homozygous deletions in 13% of CLL clones. 8 Results published on deletions in the 13q14 region are based on several different methods. Southern blot analysis requires a high proportion of leukaemia cells in the sample and it cannot distinguish between possible subclones. PCR of microsatellites requires access to normal cells from the patient and does not detect homozygous deletions, due to the presence of contaminating normal cells. Fluorescence in situ hybridisation (FISH) is rapid and analysis can also yield results in samples with a lower proportion of leukaemic cells. It also gives information on subclones in the leukaemic population.
In this paper, we describe a FISH method to study deletions in the D13S319 region using a cocktail of three overlapping cosmids. We also compare FISH results with cytogenetic analysis and Southern blot data from the D13S319 region.
Materials and methods

Patients and samples
Twenty patients with CLL were selected for the study. Ten patients had a deletion of the D13S319 region known from Southern blot hybridisation and 10 patients were not analysed previously. Leukaemic cells from peripheral blood were collected and mononuclear cells were isolated on lymphoprep gradient (Nycomed, Oslo, Norway). Cells were frozen in dimethylsulfoxide (DMSO; Merck, Darmstadt, Germany) and kept in liquid nitrogen. For Southern blot analysis the malignant B cells were sometimes separated from T cells and monocytes as previously described. 5, 8 The final purity of the leukaemic cell population was always Ͼ95%.
Cell culture and mitogen stimulation
In order to obtain metaphases from leukaemic cells for cytogenetic analyses and FISH, cells were cultured for 3-5 days with lipopolysaccharide from E. coli (LPS) mixed with either 12-0-tetradecanoylphorbol-13-acetate (TPA) or cytochalasin B (CB) as previously described 9 and harvested according to standard cytogenetic methods. The cell suspensions were kept at −20°C.
Mononuclear cells from healthy individuals were stimulated with phytohemagglutinin (PHA) during cell culture and used as normal controls.
Chromosome analysis
Metaphases were stained using the Q-banding technique and analysed in a Cytoscan Image analysis system (Applied Imaging, Sunderland, UK). The nomenclature used was according to recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. 10 Cosmid clones and DNA probes For FISH analysis, a cosmid clone was initially used that contained D13S319 (Cosmid LANL 71a11). FISH analysis using this cosmid frequently gave rise to small signals, which made interpretation difficult. Due to this we selected three cosmids overlapping with and immediately centromeric of the LANL 71a11 cosmid which were used as a 'cocktail'. These cosmids, c1a, c30a and c32a, were derived from a cosmid contig of the region. 11 The cosmids derive from a library of 13q14.2-specific cosmids isolated from the subcloning of the YAC C161. This YAC was isolated from the ICRF human YAC library and is part of a contig encompassing the region between Rb and the 3 cM telomeric marker D13S31. 12 This YAC is 350 kb in size and contains the STS markers D13S319 and D13S272. The average cosmid insert size range as determined by restriction digestion and gel electrophoresis is 38 kb.
Fluorescence in situ hybridisation FISH procedures were according to Lichter 13, 14 with modifications. 15 Cosmids were either labelled with biotin or digoxigenin (Life Technologies, Paisley, UK, and Boehringer Mannheim, Mannheim, Germany).
The analysis was commonly performed on metaphases and interphase cells after mitogen stimulation. Interphase FISH was also performed on mononuclear cells from leukaemic samples that had not been exposed to cell culture of mitogen stimulation.
In all experiments on unstimulated cells, double colour FISH using an ␣-satellite probe for chromosome 12 (Oncor, Gaithersburg, MD, USA) was performed. The ␣-satellite probe served as a control for the hybridisation efficiency in CLL cells. The percentage of cells with less than two signals was 7% (mean). Only cells with two signals from the chromosome 12 probe were used for evaluation of the number of signals of the cosmid cocktail. In patient 4 with trisomy 12, cells with three signals were also accepted for further analysis.
In all FISH experiments, normal cells were included as a control. The frequency of normal cells with less than two signals was 4% (mean).
Slides were analysed using an Olympus (Tokyo, Japan) fluorescence microscope BH2-RFCA using triple band filter and pictures were digitalized, enhanced and analysed using the Cytovision system (Applied Imaging, Sunderland, UK).
Fiber FISH DNA fibers for fiber FISH analysis was prepared as described previously with small modifications. 16 Briefly, agarose blocks containing normal blood lymphocytes were treated with proteinase K and sarcocyl (Sigma, St Louis, MO, USA). After incubation agarose plugs were transferred to pretreated slides and DNA was manually extended over the slide after heating of the agarose block in a preheated microwave oven. Double color FISH hybridisation was performed with cosmid c1a, c30a and c32a.
Southern blot analysis DNA extraction, digestion with restriction enzyme, agarose gel electrophoresis and Southern blotting were performed as previously described. 17 Filters were hybridised with a 4.3 kb probe derived from a cosmid clone designated to locus D13S319. Hybridisation patterns were compared to those obtained using a control probe, commonly the bcl-1 probes p11E2.3 and p11EH. The intensity of the bands was evaluated visually and by scanning densitometry using Ultroscan XL densitometer (LKB Pharmacia, Uppsala, Sweden).
Results
Cytogenetic analysis
Karyotype analysis was attempted in all 20 patients (Table 1) . Two patients were not evaluable due to a lack of metaphases. Seven patients had a normal karyotype and eight patients had abnormalities involving the 13q14 band.
Four patients with 13q aberrations (Nos 1, 3, 4, 8) had multiple subclones with different cytogenetic abnormalities. In patients 3 and 4, the 13q abnormality was found in the largest abnormal clone. Patient 1 had a large clone with del(6) found in 10 metaphases and del(13) was found only in three metaphases. Patient 4 had a t(13;19) with breakpoint in 13q14 in all eight metaphases and in six metaphases this was accompanied by trisomy 12.
Southern blot analysis
Southern blot analysis was performed on cells from 19 patients. Two patients retained both alleles of the D13S319 region. Hemizygous deletions of D13S319 were found in 13 patients and four patients showed homozygous deletions ( Table 2) .
FISH
All 20 patients were analysed using interphase FISH with the cosmid cocktail. Fiber FISH confirmed that the three cosmids were adjacent to each other (Figure 1a) . Interphase FISH was performed on unstimulated as well as mitogen-stimulated CLL cells. The proportion of cells with two signals rose dramatically following mitogen stimulation. Thus, the evaluation is based on unstimulated cells when available.
In three patients the major cell clone showed two signals for the 13q14 region. Thirteen patients had a hemizygous deletion in the major cell clone and the leukaemic cell clone contained a homozygous 13q14 deletion in four patients (Table 2) .
In all cases except one (patient 12) the major cell clone as analysed by FISH contained the same number of alleles as revealed by Southern blot analysis. In some patients the data suggested the existence of subclones with a variable number of 13q14 alleles. For instance, no FISH signals were observed between 16 and 21% of analysed cells from clones 1, 2, 9 and 16, suggesting small subclones with homozygous deletions of the 13q14 region. In patients with hemi-or homozygous deletions in the largest subclone, up to 42% of the cells were found to contain two signals from the 13q14 region. In patient 13 (42% cells with two signals) FACS analysis revealed that 92% of the cells had a leukaemic phenotype, suggesting that a leukaemic subclone had not deleted the 13q14 region. In a majority of the patients, however, these signals are in all likelihood derived from normal lymphoid cells.
Analysis of metaphase cells in 13 patients gave results contradictory to the interphase FISH and Southern blot data in a -11  35  2  4  2  94  2  5  93  6  0  0  100  12  37  1  2  32  66  3  5  92  5  0  20  80  13  76 (92)  1  1  57  42  9  13  79  8  25  12  62  14  218 (80)  1  9  80  11  15  48  37  -15  70  0  73  22  5  21  13  66  5  20  20  60  16  32  1  17  69  14  66  4  30  4  25  25  50  17  314  2  6  5  89  5  10  85  3  0  0  100  18  -1  10  53  37  4  2  94  -19  112  0  ND  78  2  20  -20  25  ND  10  56  34  1  2 majority of the patients. This, again, reflects the problem in using mitogen stimulation in conjunction with FISH analysis. Patient 4 had trisomy of chromosome 12. All cells with a deletion of the 13q14 region also had trisomy 12, showing that these events can occur in the same clone (Figure 1c ).
Discussion
We and other groups have reported deletions of chromosome 13q14 in CLL and there are strong indications that a still unknown tumour suppressor gene is located in the region close to the D13S319 locus. Recently, it was reported that 80% of CLL patients have subclones with deletions located on the centromeric side of the Rb gene. Several cases were shown to have a retained Rb gene region but with deletions on both sides of Rb, indicating that the region might harbour another tumor suppressor gene relevant for CLL. 18 However, these findings have not been confirmed by other groups. 19 In the present study we have compared three commonly used methods; cytogenetics, FISH and Southern blot analysis on 20 patients with CLL for detection of deletions in the region close to D13S319. The group of patients in this study is partly selected for 13q deletions, and the frequency is thus not relevant for CLL patients in general.
Eight out of 20 patients (40%) had clonal abnormalities in 13q14 as detected by cytogenetic analysis. As shown in previous studies, deletions were found in a significantly higher proportion of patients using FISH or Southern blot analysis.
The interphase FISH analysis was difficult to evaluate using the LANL 71a11 cosmid containing D13S319. Since our data of minimal region of overlap in CLL patients indicate that the relevant tumour suppressor gene is located close to D13S319, we used three overlapping cosmids from this region. The c30a cosmid overlaps the cosmid containing D13S319 by 20 kb, and the c32a and c1a cosmids are located immediately centromeric to c30a. Thus, using the cocktail we cover an area of approximately 40-60 kb immediately centromeric to the D13S319 region.
The number of alleles found with Southern blot hybridisation corresponds to the major clone found by FISH in all cases except patient 12. This patient had a hemizygous deletion detected by Southern analysis which was observed in 32% of the cells by FISH, but the dominating clone as measured by FISH analysis had no deletion of the 13q14 area. It is possible that the deletion is limited to an area close to D13S319 and that parts of the region covered by the cosmid cocktail is retained.
Our FISH data indicate that in some CLL patients subclones may appear with a variable number of 13q14 alleles. This is also in agreement with cytogenetic data.
Our study also emphasises the impact mitogen stimulation has on the leukaemic sample. A large increase in the proportion of cells with two alleles on FISH analysis was found after stimulation and cell culture. It is most likely that these cells represent normal lymphocytes. The change in proportion after stimulation can be explained by death of leukaemic cells in culture or by over-growth of normal cells in response to mitogens. The changes in proportions were in several cases great enough to disguise the 13q14 deletion.
In summary, this study shows that deletions in the D13S319 area can be efficiently detected using both Southern blot analysis and FISH with a cosmid cocktail from the region. Both methods are more sensitive than conventional cytogenetics. FISH adds more information regarding subclones in the malignant cell population and it is also a more rapid method in a clinical setting.
